US › Healthcare

NeOnc Technologies Holdings, Inc. Common Stock (NTHI)

US · Healthcare · Biotechnology

$3.43-0.87%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-8.8M
Profit YoY
+76.8%
EPS
$-0.38
EPS estimate
$-0.14

EPS came in at -0.38 against a street estimate of -0.14 — a miss of 171.4%.

Key statistics

Market cap
$90.5M
Forward P/E
0.0
P/B
0.00
Book value
$-0.55
EPS (TTM)
$-1.80
52-week high
$12.99
52-week low
$3.00
50-day MA
$4.35
200-day MA
$7.22

Analyst view

with an average price target of $16.00.

Shareholding

Insiders
58.68%
Institutions
11.77%

Largest institutional holders

FundStake
Cinctive Capital Management LP5.50%
Bank of America Corp0.91%
Vanguard Capital Management, LLC0.83%
Westmount Partners, LLC0.76%
Vanguard Group Inc0.70%
BlackRock Inc0.60%
Hudson Bay Capital Management LP0.57%
Geode Capital Management, LLC0.49%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for NeOnc Technologies Holdings, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.